News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Continue Reading Previous Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive OfficerNext EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 Related Stories News Six Students, Six Countries: Award-Winning Documentary The Moon is Yours Screens in Kuala Lumpur News Kleen Hy-Dro-Gen Inc. Is Pleased to Announce Dual ISO 9001:2015 and TSSA Certifications, Bolstering Operational Quality and Technical Safety Governance News TrustScale Launches Argus to Detect and Correct AI Hallucinations and Power Safe Enterprise AI Adoption News Agassi Sports Entertainment Launches Global “Let’s Play” Pickleball and Padel Platform Initiative News GMG’s New Website and Revitalised Branding News Focus Graphite Announces Grant of Stock Options and Restricted Share Units
